« Back to Record
Citation APA

Blumental, S., Lajot, A., Vandromme, M., Lafort, Y., Dockx, Y., Denayer, S., Wampers, A., Nebbioso, A., Tilmanne, A., Mignon, C., Tuerlinckx, D., Rigolle, H., Matthijs, I., Vandersnickt, J., Hellinckx, J., Dewulf, J., Coppens, K., Van Hoorenbeeck, K., Vanlede, K., Winters, L., Seyler, L., Parsy, M.-P., Reynders, M., Balcaen, M., Urbina, M., Dauby, N., Chatzis, O., Naesens, R., Dorval, S., Ternest, S., Vanspeybroeck, S., Goetghebuer, T., Van Ackere, T., Selimaj Kontoni, V., El Bitar, W., Holemans, X., Bruyère, Y., Van Brusselen, D., De Mot, L., & Raes, M. (2026). National real-life impact of prevention with nirsevimab on infants’ RSV hospitalizations in Belgium. BMC infectious diseases. doi:10.1186/s12879-026-13419-y


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/410008

Blumental, S., Lajot, A., Vandromme, M., Lafort, Y., Dockx, Y., Denayer, S., Wampers, A., Nebbioso, A., Tilmanne, A., Mignon, C., Tuerlinckx, D., Rigolle, H., Matthijs, I., Vandersnickt, J., Hellinckx, J., Dewulf, J., Coppens, K., Van Hoorenbeeck, K., Vanlede, K., Winters, L., Seyler, L., Parsy, M.-P., Reynders, M., Balcaen, M., Urbina, M., Dauby, N., Chatzis, O., Naesens, R., Dorval, S., Ternest, S., Vanspeybroeck, S., Goetghebuer, T., Van Ackere, T., Selimaj Kontoni, V., El Bitar, W., Holemans, X., Bruyère, Y., Van Brusselen, D., De Mot, L., & Raes, M. (2026). National real-life impact of prevention with nirsevimab on infants’ RSV hospitalizations in Belgium. BMC infectious diseases. doi:10.1186/s12879-026-13419-y